Strategic
Sarstedt acquires FaCellitate
SourcingClub was not involved in this transaction.
Sarstedt acquires FaCellitate from Mannheim, expanding its life science portfolio with solutions for 3D cell culture. FaCellitate develops polymer-based surfaces for cell culture that are used in research, drug development and toxicology.
Deal-Radar editorial team · responsible: Nick Herbig
Source from the same day: chemanager-online.com , 16 Nov 2026
Who was involved.
- Buyer
- Sarstedt
- Target
- FaCellitate, Mannheim
- Type
- Strategic
- Sector
- Surface solutions for 3D cell culture
- Country
Germany
- Source dated
- 16/11/2026
- Source
- chemanager-online.com
Deal-Radar no. 47-017 · publicly reported, no guarantee · SourcingClub was not involved in this transaction. Report an error · Sources and limits
We report publicly announced information and link the source; we accept no liability for its accuracy. No offer and no investment, legal or tax advice. The operators of linked pages are responsible for their content. We correct errors as soon as we learn of them.
November 2026 on the Deal-Radar.
79 of 190 deals so far are of the type Strategic.
- Strategic79
- Add-on32
- Carve-out23
- Funding round23
- Insolvency11
- Buy-out9
- Minority stake6
- Secondary5
- Merger1
- Succession1
Strategic and succession in Week 47/2026.
All deals in November 2026New deals every day. By email on Mondays.
All deals of the previous week in one email, with source and adviser.





